A proof-of-concept Phase IIa clinical trial to treat chronic HBV/HDV with the entry inhibitor myrcludex BPavel Bogomolov,Natalia Voronkova,Katrin Schoeneweis,Matthias Schwab,Florian A. Lempp,Mathias Haag,Heiner Wedemeyer,Alexander Alexandrov,Walter E. Haefeli,Antje Blank,Stephan UrbanHEPATOLOGY(2016)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要